Association of OSMR gene variants rs2278329 and rs2292016 with dermatomyositis and systemic lupus erythematosus in Bulgarian patients
DOI:
https://doi.org/10.2478/amb-2026-0039Keywords:
systemic lupus erythematosus, dermatomyositis, OSMR rs2278329, OSMR rs2292016Abstract
Abstract. Introduction: The precise nature of dermatomyositis (DM) and systemic lupus erythematosus (SLE) is not yet fully understood, although it is recognized that various genetic, hormonal or external factors play a significant role in the onset of autoimmune processes. This study aims to explore the link between two specific genetic variants of the oncostatin M receptor (OSMR) – rs2278329 (Asp553Asn) and rs2292016 (-100G/T) – and the predisposition to DM and SLE in Bulgarian patients. Materials and methods: A total of 126 individuals were included in the study – 62 patients with SLE, 64 with DM, and 95 healthy unrelated controls. Genotyping was performed using TaqMan assays. Results: The analysis revealed that the minor allele frequency was low. None of the genetic variants investigated showed any significant correlation with SLE, DM, or clinical characteristics associated with these conditions. Conclusions: Our findings suggest that none of the OSMR genetic variants investigated pose a significant risk for the development of dermatomyositis or systemic lupus erythematosus in Bulgarian patients.
References
Dourmishev LA. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy. Folia Med (Plovdiv). 2017; 59(1):7-13.
Shirani Z, Kucenic MJ, Carroll CL, et al. Pruritus in adult dermatomyositis. Clin Exp Dermatol. 2004; 29(3):273-6.
Kim HJ. Pruritus in autoimmune connective tissue diseases. Ann Transl Med. 2021; 9(5):441.
Dourmishev L. Dermatomyositis associated with malignancy. 12 case reports. Adv Exp Med Biol. 1999; 455:193-9.
Luu X, Leonard S, Joseph KA. Dermatomyositis presenting as a paraneoplastic syndrome with resolution of symptoms following surgical management of underlying breast malignancy. J Surg Case Rep. 2015; 2015(7):rjv075.
Kamenarska ZG, Hristova MH, Vinkov AI, et al. Monoclonal Antibody Drugs for Systemic Lupus Erythematosus. Folia Med (Plovdiv). 2015; 57(2):89-92.
Hristova M, Dourmishev L, Kamenarska Z, et al. Role of the promoter polymorphism IL-6-174G/C in dermatomyositis and systemic lupus erythematosus. Biomed Res Int. 2013:315365.
Hams E, Colmont CS, Dioszeghy V, et al. Oncostatin M receptor‑beta signaling limits monocytic cell recruitment in acute inflammation. J Immunol. 2008; 181(3):2174-80.
Tanaka M, Hara T, Copeland NG et al. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. Blood. 1999; 93(3):804-15.
Isozaki O, Tsushima T, Miyakawa M, et al. Oncostatin M: a new potent inhibitor of iodine metabolism inhibits thyroid peroxidase gene expression but not DNA synthesis in porcine thyroid cells in culture. Thyroid. 1997; 7(1):71-7.
Klausen P, Pedersen L, Jurlander J, et al. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene. 2000; 19(32):3675-83.
Bachetti T, Rosamilia F, Bartolucci et al. The OSMR Gene Is Involved in Hirschsprung Associated Enterocolitis Susceptibility through an Altered Downstream Signaling. Int J Mol Sci. 2021; 22(8):3831.
Kim WM, Kaser A, Blumberg RS. A role for oncostatin M in inflammatory bowel disease. Nat Med. 2017; 23(5):535-536.
West NR, Hegazy AN, Owens BMJ, et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med. 2017; 23(5):579-589.
Mozaffarian A, Brewer AW, Trueblood ES, et al. Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. J Immunol. 2008; 181(10):7243-53.
Datsi A, Steinhoff M, Ahmad F, et al. Interleukin-31: The “itchy” cytokine in inflammation and therapy. Allergy. 2021; 76(10):2982‑2997.
Tseng PY, Hoon MA. Oncostatin M can sensitize sensory neurons in inflammatory pruritus. Sci Transl Med. 2021; 13(619):eabe3037.
Hashimoto T, Nattkemper LA, Kim HS, et al. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta. Exp Dermatol. 2021; 30(6):804-810.
Stifano G, Sornasse T, Rice LM, et al. Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2018; 70(6):912-919.
Han L, Yan J, Li T, et al. Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis. Front Immunol. 2023; 14:1258765.
Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004; 5(7):752-60.
Nemoto O, Furue M, Nakagawa H, et al. The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study. Br J Dermatol. 2016; 174(2):296-304.
Targoff IN, Miller FW, Medsger TA Jr, et al. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1997; 9(6):527-35.
Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 64(8):2677-86.
Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003; 374(Pt 1):1-20.
Lin YZ, Li RN, Lin CH, et al. Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients. Autoimmunity. 2014; 47(1):23-6.
Hong IK, Eun YG, Chung DH, et al. Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the Korean population. Clin Exp Otorhinolaryngol. 2011; 4(4):193-8.
Deng S, He SY, Zhao P, et al. The role of oncostatin M receptor gene polymorphisms in bladder cancer. World J Surg Oncol. 2019; 17(1):30.
Dai X, Peng Y, Zhou B, et al. [Association of OSMR gene polymorphisms with dilated cardiomyopathy in a Han Chinese population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018; 35(2):210‑214.
Dai X, South AP, Hans-Filho G, et al. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet. 2008; 82(1):73-80.
Tanaka A, Arita K, Lai-Cheong JE, et al. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol. 2009; 161(6):1217‑24.
Sharma M, Samra S, Liu Y, et al. Human germline biallelic loss‑of‑function OSMR variants cause severe allergic disease. [Preprint]. 2025 Aug 8:2025.08.05.25332527. doi: 10.1101/2025.08.05.25332527.
Hojman P, Dethlefsen C, Brandt C, et al. Exercise-induced muscle‑derived cytokines inhibit mammary cancer cell growth. Am J Physiol Endocrinol Metab. 2011; 301(3):E504-10.
Lacreusette A, Nguyen JM, Pandolfino MC, et al. Loss of oncostatin M receptor beta in metastatic melanoma cells. Oncogene. 2007; 26(6):881-92.
Zhong Y, Li J, Zhang Y, et al. The polymorphisms of oncostatin M receptor gene associated with increased risk of lung cancer. Int J Clin Exp Med 2018; 11(11):12421-12428.
Miles SA, Martínez-Maza O, Rezai A, et al. Oncostatin M as a potent mitogen for AIDS‑Kaposi’s sarcoma‑derived cells. Science. 1992; 255(5050):1432-4.
Louthrenoo W, Kasitanon N, Mahanuphab P, et al. Kaposi’s sarcoma in rheumatic diseases. Semin Arthritis Rheum. 2003; 32(5):326-33.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 J. Pozharashka, R. Bozhilova, M. Hristova, Z. Kamenarska, D. Kalinova, A. Vinkov, R. Kaneva, Z. Kolarov, L. Dourmishev (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
